Antibodies, Immunity, and COVID-19
- PMID: 33231673
- PMCID: PMC8371694
- DOI: 10.1001/jamainternmed.2020.7986
Antibodies, Immunity, and COVID-19
Conflict of interest statement
Comment on
-
Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.JAMA Intern Med. 2021 Apr 1;181(4):450-460. doi: 10.1001/jamainternmed.2020.7976. JAMA Intern Med. 2021. PMID: 33231628 Free PMC article.
Similar articles
-
SARS-CoV-2 immunity and HIV infection: total recall?Lancet HIV. 2021 Jun;8(6):e312-e313. doi: 10.1016/S2352-3018(21)00097-7. Epub 2021 Apr 29. Lancet HIV. 2021. PMID: 33933190 Free PMC article. No abstract available.
-
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients.J Clin Microbiol. 2020 Nov 18;58(12):e02005-20. doi: 10.1128/JCM.02005-20. Print 2020 Nov 18. J Clin Microbiol. 2020. PMID: 32917729 Free PMC article.
-
Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.JCI Insight. 2020 Sep 17;5(18):e142386. doi: 10.1172/jci.insight.142386. JCI Insight. 2020. PMID: 32796155 Free PMC article.
-
SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.J Infect Dis. 2021 Feb 24;223(4):589-599. doi: 10.1093/infdis/jiaa737. J Infect Dis. 2021. PMID: 33247924 Free PMC article.
-
Possible vertical transmission and antibodies against SARS-CoV-2 among infants born to mothers with COVID-19: A living systematic review.J Med Virol. 2021 Mar;93(3):1361-1369. doi: 10.1002/jmv.26622. Epub 2020 Nov 10. J Med Virol. 2021. PMID: 33090535
Cited by
-
Clinical Features and Time to Recovery of Admitted COVID-19 Cases at Dilla University Referral Hospital Treatment Center, South Ethiopia.Infect Drug Resist. 2022 Mar 4;15:795-806. doi: 10.2147/IDR.S356606. eCollection 2022. Infect Drug Resist. 2022. PMID: 35281575 Free PMC article.
-
Assessment of SARS-CoV-2 Seroprevalence by Community Survey and Residual Specimens, Denver, Colorado, July-August 2020.Public Health Rep. 2022 Jan-Feb;137(1):128-136. doi: 10.1177/00333549211055137. Epub 2021 Nov 9. Public Health Rep. 2022. PMID: 34752156 Free PMC article.
-
Modeling for COVID-19 college reopening decisions: Cornell, a case study.Proc Natl Acad Sci U S A. 2022 Jan 11;119(2):e2112532119. doi: 10.1073/pnas.2112532119. Proc Natl Acad Sci U S A. 2022. PMID: 34969678 Free PMC article.
-
Design and synthesis of naturally-inspired SARS-CoV-2 inhibitors.RSC Med Chem. 2023 Jan 25;14(3):507-519. doi: 10.1039/d2md00149g. eCollection 2023 Mar 22. RSC Med Chem. 2023. PMID: 36970153 Free PMC article.
-
Pathways to Immunity: Patterns of Excess Death Across the United States and Within Closed Religious Communities.J Relig Health. 2023 Aug;62(4):2820-2835. doi: 10.1007/s10943-023-01838-z. Epub 2023 Jun 1. J Relig Health. 2023. PMID: 37261578 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical